EMEA-001154-PIP01-11
Key facts
Invented name |
ATryn
|
Active substance |
Antithrombin alfa
|
Therapeutic area |
Haematology-Hemostaseology
|
Decision number |
P/226/2011
|
PIP number |
EMEA-001154-PIP01-11
|
Pharmaceutical form(s) |
Powder for solution for infusion
|
Condition(s) / indication(s) |
Treatment of antithrombin deficiency
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
GTC Biotherapeutics UK Limited
E-mail: Dick.Scotland@gtc-bio.com |
Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|